ScinoPharm Taiwan, Ltd. Stock Price

TWSE:1789 Community·NT$16.8b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

1789 Share Price Performance

NT$21.25

2.50 (13.33%)

NT$21.25

2.50 (13.33%)

NT$21.25

Wed, 15 Apr 26

Share Pricen/a

1789 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Excellent balance sheet unattractive dividend payer.

2 Risks

0 Rewards

View Full Analysis

ScinoPharm Taiwan, Ltd. Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: 0.17
: 34.66%
: 4.33%
: 1.2%

View Full Analysis

About 1789

Founded: 1997
Employees: n/a
CEO: Li-An Lu
WebsiteView website: www.scinopharm.com

ScinoPharm Taiwan, Ltd., a pharmaceutical company, provides active pharmaceutical ingredient (API) development and manufacturing and injectable solutions in Taiwan, rest of Asia, Europe, and the Americas. It offers small molecules, peptide drugs, and steroids; drug products for anticancer, thromboembolic disorders, and osteoporosis; and contract analytical testing, sterile injectables contract manufacturing, and small molecules and peptide contract development and manufacturing organization services. The company was incorporated in 1997 and is headquartered in Tainan City, Taiwan.